NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of federal securities laws and/or violations of shareholder fiduciary duties related to:

Opiant Pharmaceuticals, Inc. OPNT‘s Sale to Individual PLC. Under the terms of the agreement, Indivior would acquire Opiant for $20.00 per share in cash, plus up to $8.00 per share in contingent stock rights, which may become payable if OPNT003 achieves certain net sales milestones during the relevant seven-year period of registration and Begin. If you are an Opiant shareholder, Click here to learn more about your rights and options.

Imago BioSciences, Inc. I GO‘s Sold to Merck for $36.00 per share in cash. If you are an Imago shareholder, Click here to learn more about your rights and options.

Salisbury Bancorp, Inc. SAL‘s Sold to NBT Bancorp Inc. for 0.7450 NBT common shares for each Salisbury share. If you are a Salisbury shareholder, Click here to learn more about your rights and options.

Shareholders are encouraged to contact the company for free to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors worldwide who have been victims of securities fraud and corporate wrongdoing. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

lawyer advertising. Previous results do not guarantee a similar result.

Contact information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com